Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation
RecruitingNCT05508841Phase: NAStarted 2022-09-01
Summary
There is currently little symptomatic therapy for Alzheimer's Disease (AD) and nothing effective for individuals with Frontotemporal dementia (FTD). However, neuromodulation with transcranial direct c
Eligibility
Sex
ALL
Min Age
50 Years
Max Age
90 Years
Locations
Baycrest Health SciencesToronto, Ontario, Canada
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05508841